Product Description
Cefatrizine 98%min supplier Pharmaceutical API Antibiotics made in china 51627-14-6
AI Product Description
*The following content is generated by AI and is for reference only.
Cefatrizine, a semi-synthetic cephalosporin antibiotic with a purity typically exceeding 98%, is a widely manufactured active pharmaceutical ingredient (API) originating from China. Its molecular formula is C16H17N5O4S2, and it is uniquely identified by the CAS Registry Number 3904-65-8. Structurally, this compound belongs to the first-generation cephalosporin class, characterized by a beta-lactam ring fused to a dihydrothiazine ring, which confers its potent bactericidal activity against a broad spectrum of Gram-positive bacteria and certain Gram-negative organisms.
The primary therapeutic application of Cefatrizine involves the treatment of various bacterial infections affecting the respiratory tract, skin, soft tissues, and urinary system. It functions by inhibiting bacterial cell wall synthesis, specifically binding to penicillin-binding proteins (PBPs), thereby preventing peptidoglycan cross-linking and leading to cell lysis. Due to its stability against many common beta-lactamases produced by staphylococci, it remains effective against methicillin-sensitive strains. Pharmaceutical manufacturers in China have established robust supply chains for high-purity Cefatrizine, catering to global demand for cost-effective generic antibiotics. The raw material is predominantly utilized in the formulation of oral tablets and capsules, offering a convenient dosage form for outpatient therapy.
While newer generations of cephalosporins exist, Cefatrizine retains relevance in specific clinical scenarios where its pharmacokinetic profile and efficacy are advantageous. Its production adheres to strict international quality standards, ensuring consistency in potency and safety for patients worldwide. As a key component in antimicrobial stewardship programs, particularly in resource-limited settings, this API plays a crucial role in managing infectious diseases. Continuous advancements in Chinese manufacturing technologies have further enhanced the yield and purity of Cefatrizine, reinforcing its status as a reliable choice for pharmaceutical companies seeking high-quality bulk ingredients. Despite the evolving landscape of antibiotic resistance, Cefatrizine continues to serve as an essential tool in the medical arsenal against susceptible bacterial pathogens.